Virbickiene, A.; Tatarunas, V.; Ciapiene, I.; Jonaitiene, N.; Jureviciute, J.; Bucius, P.; Leleika, A.; Jonauskiene, I.; Kleizaite, L.; Lapinskas, T.;
et al. Clinical and Biomarker Predictors of Adverse Left Ventricular Remodeling After First STEMI: Insights into Phenotype Variability Using CMR. Pharmaceuticals 2026, 19, 794.
https://doi.org/10.3390/ph19050794
AMA Style
Virbickiene A, Tatarunas V, Ciapiene I, Jonaitiene N, Jureviciute J, Bucius P, Leleika A, Jonauskiene I, Kleizaite L, Lapinskas T,
et al. Clinical and Biomarker Predictors of Adverse Left Ventricular Remodeling After First STEMI: Insights into Phenotype Variability Using CMR. Pharmaceuticals. 2026; 19(5):794.
https://doi.org/10.3390/ph19050794
Chicago/Turabian Style
Virbickiene, Agneta, Vacis Tatarunas, Ieva Ciapiene, Neda Jonaitiene, Justina Jureviciute, Paulius Bucius, Arnoldas Leleika, Ieva Jonauskiene, Liepa Kleizaite, Tomas Lapinskas,
and et al. 2026. "Clinical and Biomarker Predictors of Adverse Left Ventricular Remodeling After First STEMI: Insights into Phenotype Variability Using CMR" Pharmaceuticals 19, no. 5: 794.
https://doi.org/10.3390/ph19050794
APA Style
Virbickiene, A., Tatarunas, V., Ciapiene, I., Jonaitiene, N., Jureviciute, J., Bucius, P., Leleika, A., Jonauskiene, I., Kleizaite, L., Lapinskas, T., & Dobiliene, O.
(2026). Clinical and Biomarker Predictors of Adverse Left Ventricular Remodeling After First STEMI: Insights into Phenotype Variability Using CMR. Pharmaceuticals, 19(5), 794.
https://doi.org/10.3390/ph19050794
